Dr. Rustgi is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Connect with other colleagues in the same hospital or clinic
- Search all U.S. specialist profiles and refer a patient
- Read the latest clinical news and earn CME/CEU credits
Office
One Robert Wood Johnson Place
MEB 478
New Brunswick, NJ 08901Phone+1 732-235-7784Fax+1 732-235-7018- Is this information wrong?
Education & Training
- Johns Hopkins UniversityM.B.A, 2005 - 2009
- Clinical Center at the National Institutes of HealthFellowship, Liver Diseases, 1985 - 1987
- Stanford Health Care-Sponsored Stanford UniversityFellowship, Gastroenterology, 1982 - 1985
- MedStar Health/Georgetown University HospitalResidency, Internal Medicine, 1980 - 1982
- Johns Hopkins University School of MedicineClass of 1979
- Yale UniversityB.A, 1971 - 1975
Certifications & Licensure
- CA State Medical License 1982 - Present
- NY State Medical License 1986 - Present
- FL State Medical License 2022 - 2026
- VA State Medical License 1981 - 2026
- NJ State Medical License 2016 - 2025
- MD State Medical License 2002 - 2017
- PA State Medical License 1983 - 2016
- American Board of Internal Medicine Internal Medicine
- American Board of Internal Medicine Gastroenterology
- Join now to see all
Awards, Honors, & Recognition
- Fellowship Royal College of Physicians (UK), 2020-2022
- Distinguished Professorship Rutgers Robert Wood Johnson Medical School, 2020-2022
- Fellowship American Association for the Study of Liver Diseases, 2020-2022
- Join now to see all
Clinical Trials
- YM443 in Subjects With Functional Dyspepsia Start of enrollment: 2004 Mar 10
- HepeX-B in Post Hepatic Allografts for Treatment of End Stage Liver Disease Due to Hepatitis B Infection
- Study of Nitazoxanide, Peginterferon Alfa-2a and Ribavirin in Treatment-Naive Hepatitis C Patients Start of enrollment: 2008 Mar 01
- Join now to see all
Publications & Presentations
PubMed
- The impact of metabolic syndrome severity on racial and ethnic disparities in Metabolic Dysfunction-Associated Steatotic Liver Disease.John F P Bridges, Electra D Paskett, Mohamed I Elsaid, Khalid Mumtaz, Na Li, Lindsay Sobotka, Vinod K Rustgi> ;Plos One. 2024 Jan 1
- Early-Onset Colorectal Cancer: Prevalence, Risk Factors, and Clinical Features Among Commercially Insured Adults in the United States.Tait, C., Patel, A., Chen, A., Li, Y., Minacapelli, C., Rustgi, V.> ;Cureus. 2023 Nov 1
- Demographics and Outcomes Related to Wilson's Disease Patients: A Nationwide Inpatient Cohort Study.Ankoor H Patel, Meghana Ghattu, Natale Mazzaferro, Alexander Chen, Kaitlyn Catalano, Carlos D Minacapelli, Vinod Rustgi> ;Cureus. 2023 Sep 1
- Join now to see all
Journal Articles
- The disposition of 6-deoxyayclovir, a xanthine oxidase activated prodrug of acyclovir, in the isolated perfused rat liver.Jones DB, Rustgi VK, Kornhauser DM, Hoofnagle JH, Jones EA, Hepatology (2): 345-348
- Influence of lymphokines on bile flow in the rat.Rustgi VK, Jones DB, Dinarello CA, Hoofnagle JH, Liver 7: 149-154
- Hepatitis C virus treatment related anemia is associated with higher sustained virologic response rate.Sulkowski MS, Shiffman ML…Rustgi V…et al, Gastroenterology;139 (5): 1602-11, 1611.e1
- Join now to see all
Books/Book Chapters
Abstracts/Posters
- A Phase II Dose-ranging, Placebo-controlled Trial of Adefovir Dipivoxil for the Treatment of Chronic Hepatitis B Virus Infection.Jeffers L, Heathcote J, Wright T, … Rustgi V, … Jaffe HS, International Conference on Antiviral Research
- Lamivudine Treatment for One Year in Previously Untreated U.S. Hepatitis B Patients: Histologic Improvement and Hepatitis B e-antigen (HBeAg) Seroconversion.Dienstag J, Schiff E, Wright T, …Rustgi V, DDW, New Orleans
- A Randomized, Double-blind Study of Neoral vs. Sandimmune in Primary Liver Transplant Recipients with Two Year Follow-up.Donovan J, …Rustgi VK, ASTP Meeting, Chicago IL
- Join now to see all
Other
- A phase 2 dose-escalation study of albuferon combined with ribavirin in non-responders to prior interferon based therapy for chronic hepatitis C infection.Reddy KR, Rustgi VK, Zeuzem S, Gane E, Lim SG, Jia JD, Belanger B, George S, Harb G, annual European Association for the Study of the Liver Meeting
http://www.easl.ch/easl2006/program/SessionIndex.asp - Valopicitabine (NM283), alone or with peg-interferon, compared to peg Interferon/Ribavirin (PEGIFN/RBV) retreatment in hepatitis C patients with prior non-response to ...Afdhal N, O’Brien C, Godofsky E, Rodriguez-Torres M, Pappas SC, Pockros P… Rustgi VK… et al, annual European Association for the Study of the Liver Meeting
http://www.easl.ch/easl2006/program/SessionIndex.asp - Pre-dosing taribavirin prior to combination therapy with pegylated interferon alfa-2B versus standard combination dosing: 24-week interim results examining safety and ...Palmer M, Rubin R, Rustgi VK, Li D & Murphy B, annual European Association for the Study of the Liver Meeting
http://www.easl.ch/liver-meeting/program/SessionIndex.asp - Join now to see all
Press Mentions
- Study: Bariatric Surgery Reduces Risk of Heart DiseaseNovember 19th, 2022
- Weight-Loss Surgery Slashes Odds for Heart Attack in Very Obese PeopleNovember 16th, 2022
- Bariatric Surgery in NAFLD Tied to Lower Heart Disease RiskOctober 7th, 2022
- Join now to see all
Professional Memberships
- Fellow
Other Languages
- Hindi
Hospital Affiliations
- Robert Wood Johnson University HospitalNew Brunswick, New Jersey
- Largo Medical CenterLargo, Florida
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence: